Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib
出版年份 2013 全文链接
标题
Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib
作者
关键词
-
出版物
Hematology
Volume 19, Issue 1, Pages 31-41
出版商
Informa UK Limited
发表日期
2013-05-16
DOI
10.1179/1607845413y.0000000094
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
- (2011) Ana C Tahira et al. Molecular Cancer
- Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
- (2011) Theonie Anastassiadis et al. NATURE BIOTECHNOLOGY
- Apoptosis and tumor resistance conferred by Par-4
- (2010) Yanming Zhao et al. CANCER BIOLOGY & THERAPY
- The IFNG (IFN- ) Genotype Predicts Cytogenetic and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia
- (2010) D. H. Kim et al. CLINICAL CANCER RESEARCH
- Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes
- (2009) G. A. Calin et al. BLOOD
- A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib
- (2009) S. K. McWeeney et al. BLOOD
- Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
- (2009) H. Kantarjian et al. BLOOD
- SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations
- (2009) D. Nowak et al. BLOOD
- Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy
- (2009) Alfonso Quintás-Cardama et al. CANCER
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
- Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
- (2009) C. Sillaber et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors
- (2009) S. Grosso et al. MOLECULAR CANCER THERAPEUTICS
- Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
- (2008) E. Jabbour et al. BLOOD
- Characteristics of Dasatinib- and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
- (2008) S. Okabe et al. CLINICAL CANCER RESEARCH
- Long intronic noncoding RNA transcription: Expression noise or expression choice?
- (2008) Rodrigo Louro et al. GENOMICS
- Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
- (2008) Neil P. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
- (2008) A Hochhaus et al. LEUKEMIA
- MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications
- (2008) M Fabbri et al. LEUKEMIA
- Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma
- (2008) Glauber Costa Brito et al. MOLECULAR CARCINOGENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started